help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 9, 2006
Endocrinology, doi:10.1210/en.2005-1270
A more recent version of this article appeared on May 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/5/2112    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silha, J. V.
Right arrow Articles by Murphy, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silha, J. V.
Right arrow Articles by Murphy, L. J.

Submitted on October 6, 2005
Accepted on February 2, 2006

Insulin-like growth factor binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms

Josef V. Silha, Patricia C. Sheppard, Suresh Mishra, Yaoting Gui, Jacquie Schwartz, Janice G. Dodd, and Liam J. Murphy*

Departments of Physiology and Internal Medicine, University of Manitoba, Winnipeg, Canada

IGFBP-3 inhibits cell growth and promotes apoptosis by sequestering free IGFs. In addition IGFBP-3 has IGF-independent, pro-apoptotic, anti-proliferative effects on prostate cancer cells in vitro. Expression of the large T-antigen (Tag) under the probasin promoter in LPB-Tag mice results in prostate tumorigenesis. To investigate the IGF-dependent and IGF-independent effects of IGFBP-3 on prostate tumor growth we crossed LPB-Tag mice with CMVBP-3 and PGKBP-3 mice which overexpress IGFBP-3 under the cytomegalovirus promoter and the phosphoglycerate kinase promoter respectively, and also PGKmBP-3 mice that express I56G/L80G/L81G-IGFBP-3, a mutant, that does not bind IGF-I but retains IGF-independent pro-apoptotic effects in vitro. Prostate tumor size and the steady-state level of p53 were attenuated in LPB-Tag/CMVBP-3 and LPB-Tag/PGKBP-3 mice compared with LPB-Tag/Wt mice. A more marked effect was observed in LPB-Tag/CMVBP-3 compared with LPB-Tag/PGKBP-3 reflecting increased levels of transgene expression in CMVBP-3 prostate tissue. No attenuation of tumor growth was observed in LPB-Tag/PGKmBP-3 mice during the early tumor development indicating that the inhibitory effects of IGFBP-3 were most likely IGF-dependent during the initiation of tumorigenesis. At 15 weeks of age EGF receptor expression was increased in LPB-Tag/Wt and LPB-Tag/PGKmBP-3 tissue compared with LPB-Tag/PGKBP-3. IGF-receptor was increased in all transgenic mice but pAkt expression, a marker of downstream IGF-I action, was increased only in LPB-Tag/Wt and LPB-Tag/PGKmBP-3. After 15 weeks of age a marked reduction in tumor growth was apparent in LPB-Tag/PGKmBP-3 mice indicating that the IGF-independent effects of IGFBP-3 may be important in inhibiting tumor progression.




This article has been cited by other articles:


Home page
EndocrinologyHome page
G. Zappala, C. Elbi, J. Edwards, J. Gorenstein, M. M. Rechler, and N. Bhattacharyya
Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-{alpha}
Endocrinology, April 1, 2008; 149(4): 1802 - 1812.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. R. Santer, B. Moser, G. A. Spoden, P. Jansen-Durr, and W. Zwerschke
Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation
Carcinogenesis, December 1, 2007; 28(12): 2511 - 2520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Fu, J. A. Thompson, and L. A. Bach
Promotion of Cancer Cell Migration: AN INSULIN-LIKE GROWTH FACTOR (IGF)-INDEPENDENT ACTION OF IGF-BINDING PROTEIN-6
J. Biol. Chem., August 3, 2007; 282(31): 22298 - 22306.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K.-W. Lee, L. J. Cobb, V. Paharkova-Vatchkova, B. Liu, J. Milbrandt, and P. Cohen
Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3
Carcinogenesis, August 1, 2007; 28(8): 1653 - 1658.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Yin, J. Ni, M. Chen, M. A. DiMaggio, Y. Guo, and S. Yeh
The Therapeutic and Preventive Effect of RRR-{alpha}-Vitamin E Succinate on Prostate Cancer via Induction of Insulin-Like Growth Factor Binding Protein-3
Clin. Cancer Res., April 1, 2007; 13(7): 2271 - 2280.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Peng, P. J. Malloy, J. Wang, and D. Feldman
Growth Inhibitory Concentrations of Androgens Up-Regulate Insulin-Like Growth Factor Binding Protein-3 Expression via an Androgen Response Element in LNCaP Human Prostate Cancer Cells
Endocrinology, October 1, 2006; 147(10): 4599 - 4607.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. M. Adhami, F. Afaq, and H. Mukhtar
Insulin-like growth factor-I axis as a pathway for cancer chemoprevention.
Clin. Cancer Res., October 1, 2006; 12(19): 5611 - 5614.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler
Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus
J. Biol. Chem., August 25, 2006; 281(34): 24588 - 24601.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Cohen
Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age.
Endocrinology, May 1, 2006; 147(5): 2109 - 2111.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society